C P Bearcroft1, G C Toms, S J Williams
1Department of Chemical Pathology, London Hospital, UK.
Patients needing thyroxine replacement after radioiodine therapy for Graves' disease require lower doses than those with autoimmune hypothyroidism. Careful monitoring of thyroid-stimulating hormone (TSH) is crucial to avoid overtreatment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: